Cited by 265Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthLipid metabolism and disorders

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

Open access

Brinton, E A, Eisenberg, S, Breslow, J L·1994·Arteriosclerosis and Thrombosis: A Journal of Vascular Biology

Open this paper in CoChat — free account Open PDF

Abstract

High-density lipoprotein (HDL) cholesterol (HDL-C) levels are a strong inverse predictor of atherosclerosis risk, but the physiological determinants of HDL-C levels are poorly understood. We selected 57 human subjects (30 women and 27 men) with a broad range of HDL-C levels and performed turnover studies of apolipoprotein (apo)A-I and apoA-II, the two major apolipoproteins of HDL, to measure the fractional catabolic rate (FCR) and production or transport rate (TR) of these proteins. We also measured several other parameters known to correlate with HDL-C levels to test for their interrelations and to postulate mechanisms of regulation of HDL-C levels. As expected, the women had higher levels of HDL-C (56.7 +/- 21.4 versus 45.1 +/- 16.3 mg/dL, mean +/- SD; P = .03) and apoA-I (147 +/- 32 versus 126 +/- 29 mg/dL, P = .01) than men and did not differ in apoA-II levels (34.5 +/- 7.4 versus 33.3 +/- 7.5 mg/dL, P > .2). The FCR of apoA-I tended to be lower in the women (0.248 +/- 0.077 versus 0.277 +/- 0.069 pools/d, P = .1), although the difference was not statistically significant. The FCR of apoA-II was also lower (0.184 +/- 0.043 versus 0.216 +/- 0.056 pools/d, P = .02). In contrast, the apoA-I TR was equal in women and men (12.0 +/- 1.6 versus 12.1 +/- 2.8 mg/kg per day, P > .2), and there was a trend toward lower apoA-II TR in women (2.19 +/- .62 versus 2.61 +/- 1.06 mg/kg per day, P = .07). Linear regression analysis revealed a strong inverse correlation between HDL-C levels and the FCRs of apoA-I and apoA-II (r = -.81 and -.76, respectively; P < .0001 for both). In contrast, there was little or no association between HDL-C and the TRs of apoA-I and apoA-II (r = .06 and -.35, P = not significant and .01, respectively). In stepwise multiple linear regression analysis, apoA-I FCR alone accounted for 66% of the variability in HDL-C; two other variables accounted for an additional 7%. Due to the importance of apoA-I FCR, its determinants were sought among the remaining variables.(ABSTRACT TRUNCATED AT 400 WORDS)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.14.5.707

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
A biometric study of basal metabolism in man
Harris, J. A., & Benedict, F. G. (2014) · Medical Entomology and Zoology · Cited by 1,847
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212
Self-citation
The Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine and Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 831
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Cheung, M. C., & Albers, J. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108767 · Cited by 381
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
Schaefer, E. J., Foster, D. M., Zech, L. A., Lindgren, F. T., Brewer, H. B., & Levy, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337
Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique.
Sadur, C. N., & Eckel, R. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110547 · Cited by 288
Transport of Very Low Density Lipoprotein Triglycerides in Varying Degrees of Obesity and Hypertriglyceridemia
Grundy, S. M., Mok, H. Y. I., Zech, L. A., Steinberg, D. H., & Berman, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109422 · Cited by 283
A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114405 · Cited by 258
Self-citation

Flagged first, then by citations

Show all 36 references

1 of the 36 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Miller NE. High density lipoprotein as a predictor of clinical coronary heart disease. In: Fidge NH, Nestel PJ, eds. Athero- sclerosis VII. Amsterdam, the Netherlands: Elsevier; 1986:61.
National Health and Nutrition Examination Survey. Dietary intake source data, 11. Hyattsville, Md: National Center for Health Statistics; Office of Health Research Statistics and Technology; 1983:48-52.
Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipo- protein lipase. J Clin Invest. 1982;69:1119-1125.

Sorted by citations

Items 101–200 of 264

Abnormal HDL Apolipoprotein A-I and A-II Kinetics in Hemodialysis Patients
Okubo, K., Ikewaki, K., Sakai, S., Tada, N., Kawaguchi, Y., & Mochizuki, S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000117286.85443.7d · Cited by 56
Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes
Khavandi, M., Duarte, F., Ginsberg, H. N., & Reyes‐Soffer, G. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0818-1 · Cited by 58
Pathophysiology of diabetic dyslipidemia:implications for atherogenesis and treatment
Sugden, M., & Holness, M. (2011) · Clinical Lipidology · doi:10.2217/clp.11.32 · Cited by 55
Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days
Desager, J., Horsmans, Y., Vandenplas, C., & Harvengt, C. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05859-5 · Cited by 54
Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography
Nanjee, M. N., & Brinton, E. A. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.2.207 · Cited by 54
Self-citation
Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol
Kark, J. D., Sinnreich, R., Leitersdorf, E., Friedlander, Y., Shpitzen, S., & Luc, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00408-6 · Cited by 54
High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics
Ji, J., Watts, G. F., Johnson, A. G., Chan, D. C., Ooi, E. M. M., Rye, K., Serone, A., & Barrett, P. H. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1895 · Cited by 53
HDL-cholesterol: Is it really good?
Santos‐Gallego, C. G., Ibáñez, B., & Badimón, J. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.04.020 · Cited by 54
Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver
Duverger, N., Viglietta, C., Berthou, L., Emmanuel, F., Tailleux, A., Nihoul, L. P., Laine, B., Fiévet, C., Castro, G. R., Fruchart, J., et al. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1424 · Cited by 52
Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene
Séguret-Macé, S., Latta‐Mahieu, M., Castro, G. R., Luc, G., Fruchart, J., Rubin, E., Denèfle, P., & Duverger, N. (1996) · Circulation · doi:10.1161/01.cir.94.9.2177 · Cited by 52
Lipid and Lipoprotein Factors Associated With Variation in Lp(a) Density
Rainwater, D. L., Ludwig, M. J., Haffner, S. M., & VandeBerg, J. L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.3.313 · Cited by 48
Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome
Ooi, E. M. M., Watts, G. F., Nestel, P. J., Sviridov, D., Hoang, A., & Barrett, P. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0854 · Cited by 45
High‐density Lipoprotein Apolipoprotein A‐I Kinetics in Obesity
Ooi, E. M. M., Watts, G. F., Farvid, M. S., Chan, D. C., Allen, M. C., Zilko, S. R., & Barrett, P. H. R. (2005) · Obesity Research · doi:10.1038/oby.2005.118 · Cited by 44
Androgens, cardiovascular risk factors and atherosclerosis
von Eckardstein, A. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_8 · Cited by 44
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040109 · Cited by 44
Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin
Sviridov, D., Hoang, A., Ooi, E. M. M., Watts, G. F., Barrett, P. H. R., & Nestel, P. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.007 · Cited by 44
A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency
Huang, W., Sasaki, J., Matsunaga, A., Nanimatsu, H., Moriyama, K., Han, H., Kugi, M., Koga, T., Yamaguchi, K., & Arakawa, K. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.3.389 · Cited by 44
Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.
Brousseau, M., Santamarina-Fojo, S., Zech, L. A., Bérard, A. M., Vaisman, B. L., Meyn, S. M., Powell, D., Brewer, H. B., & Hoeg, J. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118614 · Cited by 44
In VivoEvidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus1
Frénais, R., Nazih, H., Ouguerram, K., Maugeais, C., Zaïr, Y., Bard, J., Charbonnel, B. H., Magot, T., & Krempf, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7480 · Cited by 43
Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
Millar, J. S., Duffy, D., Gadi, R., Bloedon, L. T., Dunbar, R. L., Wolfe, M. L., Movva, R., Shah, A., Fuki, I. V., McCoy, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171223 · Cited by 44
Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice
Tsujita, M., TOMIMOTO, S., Okumura‐Noji, K., Okazaki, M., & Yokoyama, S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00061-5 · Cited by 41
Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I
Jauhiainen, M., Huuskonen, J., Baumann, M., Metso, J., Oka, T., Egashira, T., Hattori, H., Olkkonen, V. M., & Ehnholm, C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32144-1 · Cited by 40
Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo
Braschi, S., Neville, T. A.-M., Vohl, M., & Sparks, D. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32457-3 · Cited by 40
Fish-eye disease: Structural and in vivo metabolic abnormalities of high-density lipoproteins
Elkhalil, L., Majd, Z., Bakir, R., Pérez-Méndez, O. A., Castro, G. R., Poulain, P., Lacroix, B. D., Duhal, N., Fruchart, J., & Luc, G. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90180-3 · Cited by 39
Inflammation, high-density lipoprotein and cardiovascular dysfunction
Haas, M. J., & Mooradian, A. D. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328344b724 · Cited by 38
High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency
Tani, M., Horvath, K. V., Lamarche, B., Couture, P., Burnett, J. R., Schaefer, E. J., & Asztalos, B. F. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.014 · Cited by 39
Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women
Vajó, Z., Terry, J. G., & Brinton, E. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00610-4 · Cited by 39
Self-citation
Cardiovascular Fitness, Body Composition, and Lipoprotein Lipid Metabolism in Older Men
Goldberg, A. P., Busby‐Whitehead, M. J., Katzel, L. I., Krauss, R. M., Lumpkin, M., & Hagberg, J. M. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.6.m342 · Cited by 39
Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
Leroux, G., Lemieux, I., Lamarche, B., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90688-7 · Cited by 39
Cardiovascular risk factors in women
Williams, C. M. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970040 · Cited by 39
Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations
Tatò, F., Vega, G. L., & Grundy, S. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.4.446 · Cited by 39
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
Reyes‐Soffer, G., Millar, J. S., Ngai, C. I., Jumes, P. A., Coromilas, E. J., Asztalos, B. F., Johnson‐Levonas, A. O., Wagner, J. A., Donovan, D. S., Karmally, W., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306680 · Cited by 38
Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans
Marsh, J. B., Welty, F. K., & Schaefer, E. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00006 · Cited by 38
The Atherogenic Significance of an Elevated Plasma Triglyceride Level
Ooi, T. C., & Ooi, D. S. (1998) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369891234255 · Cited by 37
Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations
Asztalos, B. F., LeFevre, M. L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Wong, L., & Roheim, P. S. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1885 · Cited by 37
An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway
Lu, J. J.-Q., Hübner, K., Nanjee, M. N., Brinton, E. A., & Mazer, N. A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003509 · Cited by 37
Self-citation
In Vivo Metabolism of ApoB, ApoA-I, and VLDL Triglycerides in a Form of Hypobetalipoproteinemia Not Linked to the ApoB Gene
Elias, N., Patterson, B. W., & Schonfeld, G. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1309 · Cited by 32
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans
Cohn, J. S., Batal, R., Tremblay, M., Jacques, H., Veilleux, L., Rodriguez, C., Mamer, O., & Davignon, J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300209-jlr200 · Cited by 35
Transcription factors as drug targets: opportunities for therapeutic selectivity.
Butt, T. R., & Karathanasis, S. K. (1995) · Europe PMC (PubMed Central) · Cited by 35
Effect of Niacin on High-Density Lipoprotein Apolipoprotein A-I Kinetics in Statin-Treated Patients With Type 2 Diabetes Mellitus
Pang, J., Chan, D. C., Hamilton, S. J., Tenneti, V. S., Watts, G. F., & Barrett, P. H. R. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302019 · Cited by 34
Postprandial lipaemia and vascular disease
Kolovou, G., & Ooi, T. C. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283606971 · Cited by 32
Proteolysis of Apolipoprotein A-I by Secretory Phospholipase A2
Cavigiolio, G., & Jayaraman, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525717 · Cited by 34
Novel serum paraoxonase activity assays are associated with coronary artery disease
Martinelli, N., Girelli, D., Olivieri, O., Guarini, P., Bassi, A., Trabetti, E., Friso, S., Pizzolo, F., Bozzini, C., Tenuti, I., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.108 · Cited by 33
2 H 2 O-Based High-Density Lipoprotein Turnover Method for the Assessment of Dynamic High-Density Lipoprotein Function in Mice
Kasumov, T., Willard, B. B., Li, L., Li, M., Conger, H., Buffa, J. A., Previs, S. F., McCullough, A. J., Hazen, S. L., & Smith, J. D. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301700 · Cited by 33
Insulin Resistance, Compensatory Hyperinsulinemia, and Coronary Heart Disease: Syndrome X Revisited
Reaven, G. M. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070238 · Cited by 32
Admixture mapping of quantitative trait loci for blood lipids in African-Americans
Basu, A., Tang, H., Lewis, C. E., North, K. E., Curb, J. D., Quertermous, T., Mosley, T. H., Boerwinkle, E., Zhu, X., & RISCH, N. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp122 · Cited by 33
Subjects With ApoA-I(Lys 107 →0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII)
Tilly-Kiesi, M., Lichtenstein, A. H., Ordovás, J. M., Dolnikowski, G. G., Malmström, R., Taskinen, M., & Schaefer, E. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.5.873 · Cited by 32
Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-IZaragoza (L144R)
Recalde, D., Velez‐Carrasco, W., Civeira, F., Cenarro, A., Gómez‐Coronado, D., Ordovás, J. M., & Pocovı́, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00555-4 · Cited by 32
Mechanisms of HDL deficiency in mice overexpressing human apoA-II
Julve, J., Escolá‐Gil, J. C., Ribas, V., González‐Sastre, F., Ordóñez‐Llanos, J., Sánchez‐Quesada, J. L., & Blanco‐Vaca, F. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200081-jlr200 · Cited by 32
Apolipoprotein A-I and A-II Kinetic Parameters as Assessed by Endogenous Labeling With [ 2 H 3 ]Leucine in Middle-Aged and Elderly Men and Women
Velez‐Carrasco, W., Lichtenstein, A. H., Li, Z., Dolnikowski, G. G., Lamon‐Fava, S., Welty, F. K., & Schaefer, E. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.801 · Cited by 32
Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
Quintão, E. C. R. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05531-z · Cited by 32
Association of heterozygous familial hypercholesterolemia with smaller HDL particle size
Hogue, J., Lamarche, B., Gaudet, D., Tremblay, A. J., Després, J., Bergeron, J., Gagné, C., & Couture, P. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.023 · Cited by 31
Endothelial lipase: direct evidence for a role in HDL metabolism
Cohen, J. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17744 · Cited by 31
Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment
Gagnon, F., Jarvik, G. P., Motulsky, A. G., Deeb, S. S., Brunzell, J. D., & Wijsman, E. M. (2003) · Human Genetics · doi:10.1007/s00439-003-1006-5 · Cited by 31
Diabetes and dyslipidemia
Ginsberg, H. N., & Tuck, C. H. (2001) · Current Diabetes Reports · doi:10.1007/s11892-001-0017-7 · Cited by 30
HDL and Lifestyle Interventions
Escolá‐Gil, J. C., Julve, J., Griffin, B. A., Freeman, D. J., & Blanco‐Vaca, F. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_18 · Cited by 29
Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects
Tilly-Kiesi, M., Lichtenstein, A. H., Joven, J., Vilella, E., Cheung, M. C., Velez‐Carrasco, W., Ordovás, J. M., Dolnikowski, G., & Schaefer, E. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3513 · Cited by 30
Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes
Sprecher, D. L., Harris, B. V., Stein, E. A., Bellet, P. S., Keilson, L., & Simbartl, L. A. (1996) · Circulation · doi:10.1161/01.cir.94.12.3239 · Cited by 30
Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase
Brousseau, M. E., Wang, J., Demosky, S. J., Vaisman, B. L., Talley, G. D., Santamarina-Fojo, S., Brewer, H. B., & Hoeg, J. M. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32184-2 · Cited by 30
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients
Brites, F. D., Cavallero, E., Geitere, C. D., Nicolaı̈ew, N., JACOTOT, B., Rosseneu, M., Fruchart, J., Wikinski, R. L. W., & Castro, G. R. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00155-7 · Cited by 29
The relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levels
Williams, P. T. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.004 · Cited by 29
Possible Risk Factors of Carotid Artery Atherosclerosis in the Japanese Population. A Primary Prevention Study in Non-diabetic Subjects.
Okada, M., Miida, T., Hama, H., Yata, S., SUNAGA, T., Tsuda, A., & Saitō, H. (2000) · Internal Medicine · doi:10.2169/internalmedicine.39.362 · Cited by 28
Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans?
Rashid, S., Patterson, B. W., & Lewis, G. F. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600008-jlr200 · Cited by 28
Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus
Frénais, R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00723-1 · Cited by 27
Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese
Tan, K. C. B. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00718-8 · Cited by 27
Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model
Lamarche, B., Uffelman, K. D., Steiner, G. A., Barrett, P. H. R., & Lewis, G. F. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32540-2 · Cited by 27
Atherosclerosis and the Mouse: A Decade of Experience
Plump, A. S. (1997) · Annals of Medicine · doi:10.3109/07853899708999336 · Cited by 27
ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia
Martín-Campos, J. M., Julve, J., Escolá‐Gil, J. C., Ordóñez‐Llanos, J., Gómez, J., Binimelis, J., González‐Sastre, F., & Blanco‐Vaca, F. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30194-2 · Cited by 26
Research Communication: Plasma Leptin and the Cholesterol Saturation of Bile Are Correlated in Obese Women after Weight Loss
Méndez‐Sánchez, N., Fernández, V. G., King-Martínez, A. C., Sánchez, H., & Uribe, M. (2002) · Journal of Nutrition · doi:10.1093/jn/132.8.2195 · Cited by 26
Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis
Francis, G. A., & Perry, R. J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00103-5 · Cited by 26
Trimerization of Apolipoprotein A-I Retards Plasma Clearance and Preserves Antiatherosclerotic Properties
Graversen, J. H., Laurberg, J. M., Andersen, M. H., Falk, E., Nieland, J. D., Christensen, J., Etzerodt, M., Thøgersen, H. C., & Moestrup, S. K. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31815ed0b9 · Cited by 25
Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease
Hughes, T. A., Elam, M. B., Applegate, W. B., Bond, M. G., Hughes, S. M., Wang, X., Tolley, E. A., Bittle, J. B., Stentz, F. B., & Kang, E. S. (1995) · Metabolism · doi:10.1016/0026-0495(95)90108-6 · Cited by 25
Incremento de las HDL como arma terapéutica en la aterotrombosis
Badimón, J. J., & Ibáñez, B. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70091-9 · Cited by 25
Severe acquired (secondary) high-density lipoprotein deficiency
Goldberg, R. B., & Mendez, A. J. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.02.003 · Cited by 24
Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case–control study
Zhang, P., Gao, J., Pu, C., Feng, G. L., Wang, L., Huang, L., Tao, Q., & Zhang, Y. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0325-1 · Cited by 23
Relation of the −514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy
Yamakawa‐Kobayashi, K., Somekawa, Y., Fujimura, M., Tomura, S., Arinami, T., & Hamaguchi, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00675-x · Cited by 23
Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men
Mauger, J., Couture, P., Paradis, M., & Lamarche, B. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.022 · Cited by 22
Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease
Brinton, E. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.012 · Cited by 22
Self-citation
Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease
Brinton, E. A. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.02.007 · Cited by 22
Self-citation
Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia
Gagnon, F., Jarvik, G. P., Badzioch, M. D., Motulsky, A. G., Brunzell, J. D., & Wijsman, E. M. (2005) · Human Genetics · doi:10.1007/s00439-005-1338-4 · Cited by 21
Lipoprotein metabolism in subjects with hepatic lipase deficiency
Tilly-Kiesi, M., Schaefer, E. J., Knudsen, P., Welty, F. K., Dolnikowski, G. G., Taskinen, M., & Lichtenstein, A. H. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.020 · Cited by 20
The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study)
Luc, G., Bard, J., Evans, A., Arveiler, D., Ruidavets, J., Amouyel, P., & Ducimetière, P. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00484-0 · Cited by 20
Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events
Zhu, Y. M., Verma, S., Fung, M., McQueen, M., Anderson, T. J., & Lonn, E. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.004 · Cited by 19
Fatty Acids Modulate Lecithin:Cholesterol Acyltransferase Secretion Independently of Effects on Triglyceride Secretion in Primary Rat Hepatocytes
Fungwe, T. V., Kudchodkar, B. J., Lacko, A. G., & Dory, L. (1998) · Journal of Nutrition · doi:10.1093/jn/128.8.1270 · Cited by 19
Diacylglycerol is the preferred substrate in high density lipoproteins for human hepatic lipase
Coffill, C. R., Ramsamy, T. A., Hutt, D. M., Schultz, J. R., & Sparks, D. L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34936-1 · Cited by 18
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development
Zhao, L., Jin, W., Rader, D. J., Packard, C. J., & Feuerstein, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.014 · Cited by 17
Production rate determines plasma concentration of large high density lipoprotein in non-human primates
Colvin, P. L., Moriguchi, E. H., Barrett, P. H. R., Parks, J. S., & Rudel, L. L. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32506-2 · Cited by 17
Association of waist circumference with ApoB to ApoAI ratio in black and white Americans
Okosun, I. S., Prewitt, T., Liao, Y., & Cooper, R. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800849 · Cited by 17
High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians: A cross sectional study
Sabin, A. M., Zuliani, G., Palmieri, E., Volpato, S., Bader, G., Mezzetti, A., Costantini, F., Sforza, G. R., Imbastaro, T., Romagnoni, F., et al. (1997) · Aging Clinical and Experimental Research · doi:10.1007/bf03339612 · Cited by 17
Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys
Brodeur, M. R., Rhainds, D., Charpentier, D., Mihalache-Avram, T., Mecteau, M., Brand, G., Chaput, E., Perez, A., Niesor, E. J., Rhéaume, É., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m068940 · Cited by 17
Increasing High-Density Lipoprotein as a Therapeutic Target in Atherothrombotic Disease
Badimón, J. J., & Ibáñez, B. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70065-7 · Cited by 17
Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits
Rashid, S., Uffelman, K. D., Barrett, P. H. R., Vicini, P., Adeli, K., & Lewis, G. F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31688-6 · Cited by 16
Plasma proteomic analysis in obese and overweight prepubertal children
Galata, Z., Moschonis, G., Makridakis, M., Dimitraki, P., Nicolaides, N. C., Μanios, Y., Bartzeliotou, Α., Chrousos, G. P., & Charmandari, E. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02536.x · Cited by 15
Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients
Kimak, E., Hałabiś, M., & Baranowicz-Gąszczyk, I. (2010) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1000012 · Cited by 15
Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients
von Eckardstein, A., Huang, Y., Kastelein, J. J. P., Geisel, J., Real, J. T., Kuivenhoven, J. A., Miccoli, R., Noseda, G., & Assmann, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00280-3 · Cited by 15
Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome
He, L., Wu, P., Tan, L., Bai, L., Du, W., Shen, T., Wu, J., Xiang, Z., & Hu, M. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0556-9 · Cited by 14
Effects of treatment with Sandostatin®LAR®on small dense LDL and remnant‐like lipoproteins in patients with acromegaly
Tan, K. C. B., Pang, R. W. C., Tiu, S. C., & Lam, K. S. L. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01849.x · Cited by 14
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · PubMed Central · Cited by 15
Genetic control of apolipoprotein A-I distribution among HDL subclasses
Rainwater, D. L., Blangero, J., Moore, P. H., Shelledy, W. R., & Dyer, T. D. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05623-8 · Cited by 14
Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin:cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells
Ohnsorg, P. M., Mary, J.-L., Rohrer, L., Pech, M., Fingerle, J., & von Eckardstein, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.001 · Cited by 13

Authors: Brinton, E. A., Eisenberg, S., & Breslow, J. L.
Affiliations: Rockefeller University (US)
ORCID: Brinton, E A
Breslow, J L
Venue: Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1994-05
Volume: 14
Issue: 5
Pages: 707-720
ISSN: 1049-8834 (ISSN-L)
DOI: 10.1161/01.atv.14.5.707
OpenAlex: W2155588817
Cited by: 265
References: 36
Citations by year: 2026: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 3
FWCI: 16.95
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Pew Charitable Trusts
Memorial Sloan-Kettering Cancer Center
National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL-36461, HL32435)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: HDL cholesterol, apolipoprotein A-I, apolipoprotein A-II, fractional catabolic rate, HDL particle size, sex differences, hepatic lipase, lipoprotein lipase, triglycerides, insulin, body fat distribution, atherosclerosis risk
MeSH terms: Adipose Tissue, Adult, Aged, Female, Humans, Insulin, Lipase, Lipoprotein Lipase, Lipoproteins, HDL, Cholesterol, HDL, Liver, Male, Middle Aged, Particle Size, Regression Analysis, Sex Factors, Triglycerides, Apolipoprotein A-I, Apolipoprotein A-II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks